Trials / Completed
CompletedNCT02139930
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,250 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this project is to compare two different approaches to reducing levels of nicotine in cigarettes: an immediate reduction in nicotine content in cigarettes to non-addictive levels or a gradual reduction in nicotine content in cigarettes to non-addictive levels. These two approaches will then be contrasted to a group that continues to smoke cigarettes with nicotine content similar to conventional cigarettes.
Detailed description
This project will be conducted to compare product use patterns and biomarkers of exposure between smokers who are assigned to a) gradual reduction in reduced nicotine content (RNC) cigarettes; b) immediate reduction to very low nicotine content (VLNC) cigarettes or c) normal nicotine content (NNC) cigarettes. The outcomes from this study will provide information on different approaches to reducing levels of nicotine in cigarettes and will determine the approach with the most optimal outcomes taking into account the balance between overall risk reduction (possibly maximized by abrupt switching) and compliance and acceptability (possibly maximized by gradual reduction of RNC cigarettes).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Normal Nicotine Control Group | Participants will smoke experimental cigarettes for a period of 20-weeks. |
| BEHAVIORAL | Immediate Nicotine Reduction Group | Participants will smoke experimental cigarettes for a period of 20-weeks. |
| BEHAVIORAL | Gradual Nicotine Reduction Group | Participants will smoke experimental cigarettes for a period of 20-weeks. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-14
- First posted
- 2014-05-16
- Last updated
- 2018-08-15
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02139930. Inclusion in this directory is not an endorsement.